{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:41:08Z","timestamp":1786714868171,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0301-4738.195010","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:42:41Z","timestamp":1480552961000},"page":"702","source":"Crossref","is-referenced-by-count":41,"title":["Recombinant interferon alpha 2b for ocular surface squamous neoplasia: An efficient and cost-effective treatment modality in Asian Indian patients"],"prefix":"10.4103","volume":"64","author":[{"given":"Swathi","family":"Kaliki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadiya","family":"Iram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharani","family":"Tripuraneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.195010-1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0039-6257(05)80054-2","article-title":"Ocular surface squamous neoplasia","author":"Lee","year":"1995","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/0301-4738.195010-2","doi-asserted-by":"crossref","unstructured":"Shields JA, Shields CL, De Potter P. Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan Lecture. Arch Ophthalmol 1997;115:808-15.","DOI":"10.1001\/archopht.1997.01100150810025"},{"key":"key-10.4103\/0301-4738.195010-3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1442-9071.2009.02092.x","article-title":"Plaque brachytherapy for the management of ocular surface malignancies with corneoscleral invasion","author":"Walsh-Conway","year":"2009","journal-title":"Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.195010-4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jamaophthalmol.2014.86","article-title":"Plaque radiotherapy in the management of scleral-invasive conjunctival squamous cell carcinoma: An analysis of 15 eyes","author":"Arepalli","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"key-10.4103\/0301-4738.195010-5","first-page":"292","article-title":"Orbital exenteration with eyelid sparing: Indications, technique, and results","author":"Shields","year":"1991","journal-title":"Ophthalmic Surg"},{"key":"key-10.4103\/0301-4738.195010-6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0002-9394(02)01400-9","article-title":"Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma","author":"Shields","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.195010-7","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.eye.6702126","article-title":"Neoadjuvant topical mitomycin C chemotherapy for conjunctival and corneal intraepithelial neoplasia","author":"Singh","year":"2006","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.195010-8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/bjo.84.3.268","article-title":"Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil","author":"Midena","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.195010-9","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/S0161-6420(00)00389-4","article-title":"5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea","author":"Yeatts","year":"2000","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.195010-10","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/S0161-6420(95)30866-4","article-title":"Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea","author":"Yeatts","year":"1995","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.195010-11","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0002-9394(02)01569-6","article-title":"Treatment of conjunctival squamous cell carcinoma with topical cidofovir","author":"Sherman","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.195010-12","doi-asserted-by":"crossref","unstructured":"Besley J, Pappalardo J, Lee GA, Hirst LW, Vincent SJ. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b. Am J Ophthalmol 2014;157:287-93.e2.","DOI":"10.1016\/j.ajo.2013.10.012"},{"key":"key-10.4103\/0301-4738.195010-13","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.ophtha.2010.03.052","article-title":"Subconjunctival\/perilesional recombinant interferon a2b for ocular surface squamous neoplasia: A 10-year review","author":"Karp","year":"2010","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.195010-14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/ICO.0b013e3182523f61","article-title":"Interferon for ocular surface squamous neoplasia in 81 cases: Outcomes based on the American Joint Committee on Cancer classification","author":"Shields","year":"2013","journal-title":"Cornea"},{"key":"key-10.4103\/0301-4738.195010-15","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.ophtha.2013.11.017","article-title":"Surgical versus medical treatment of ocular surface squamous neoplasia: A comparison of recurrences and complications","author":"Nanji","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.195010-16","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0161-6420(01)00577-2","article-title":"Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b","author":"Karp","year":"2001","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.195010-17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0161-6420(99)90009-X","article-title":"Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia","author":"Vann","year":"1999","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.195010-18","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/bjo.2009.160820","article-title":"Topical chemotherapy for ocular surface squamous neoplasia: Current status","author":"Sepulveda","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.195010-19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/08820530500351694","article-title":"Topical medical therapies for ocular surface tumors","author":"Poothullil","year":"2006","journal-title":"Semin Ophthalmol"},{"key":"key-10.4103\/0301-4738.195010-20","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ophtha.2011.11.035","article-title":"Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction","author":"Kim","year":"2012","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.195010-21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archophthalmol.2011.385","article-title":"Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: Outcomes based on American Joint Committee on Cancer classification","author":"Shah","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.195010-22","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/archopht.1994.01090210029007","article-title":"Regression of limbal epithelial dysplasia with topical interferon","author":"Maskin","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.195010-23","doi-asserted-by":"crossref","unstructured":"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A 3rd, editors. Carcinoma of the conjunctiva. In: AJCC Cancer Staging Manual. 7th ed. New York, Dordrecht, Heidelberg, London: Springer; 2010. p. 531-7.","DOI":"10.1007\/978-0-387-88441-7_49"},{"key":"key-10.4103\/0301-4738.195010-24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/00063030-200216040-00003","article-title":"Potential of interferon-alpha in solid tumours: Part 1","author":"Decatris","year":"2002","journal-title":"BioDrugs"},{"key":"key-10.4103\/0301-4738.195010-25","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.4049\/jimmunol.155.4.2240","article-title":"IL-10 production in cutaneous basal and squamous cell carcinomas.A mechanism for evading the local T cell immune response","author":"Kim","year":"1995","journal-title":"J Immunol"},{"key":"key-10.4103\/0301-4738.195010-26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ijc.2910570115","article-title":"Synergistic effect of retinoids and interferon alpha on tumor-induced angiogenesis: Anti-angiogenic effect on HPV-harboring tumor-cell lines","author":"Majewski","year":"1994","journal-title":"Int J Cancer"},{"key":"key-10.4103\/0301-4738.195010-27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0166-3542(94)90066-3","article-title":"HPV replication in experimental models: Effects of interferon","author":"Gangemi","year":"1994","journal-title":"Antiviral Res"},{"key":"key-10.4103\/0301-4738.195010-28","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.ophtha.2015.07.007","article-title":"Human papilloma virus infection does not predict response to interferon therapy in ocular surface squamous neoplasia","author":"Galor","year":"2015","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.195010-29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/IOP.0b013e318203d605","article-title":"Ocular surface squamous neoplasia (squamous cell carcinoma) of the socket: Management of extensive tumors with interferon","author":"Shields","year":"2011","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"key-10.4103\/0301-4738.195010-30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00003226-200201000-00003","article-title":"Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b","author":"Schechter","year":"2002","journal-title":"Cornea"},{"key":"key-10.4103\/0301-4738.195010-31","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.ophtha.2007.10.039","article-title":"Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b","author":"Schechter","year":"2008","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.195010-32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1442-9071.2006.01226.x","article-title":"Interferon alpha 2b treatment for residual ocular surface squamous neoplasia unresponsive to excision, cryotherapy and mitomycin-C","author":"Nemet","year":"2006","journal-title":"Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.195010-33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/bjo.2008.153197","article-title":"Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: A dose comparison study","author":"Galor","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.195010-34","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/bjo.2004.063339","article-title":"Treatment of biopsy proved conjunctival intraepithelial neoplasia with topical interferon alfa-2b","author":"Esquenazi","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.195010-35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ophtha.2015.10.043","article-title":"Surgical versus medical treatment of ocular surface squamous neoplasia: A cost comparison","author":"Moon","year":"2016","journal-title":"Ophthalmology"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:22:27Z","timestamp":1786713747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0301-4738.195010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"alternative-id":["195010"],"URL":"https:\/\/doi.org\/10.4103\/0301-4738.195010","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}